Paschall AV, Yang D, Lu C, Redd PS, Choi JH, Heaton CM, Lee JR, Nayak-Kapoor A, Liu K: CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype. Oncotarget. 2016, 7 (48): 78698-78712.
Liu M, Fu X, Jiang L, Ma J, Zheng X, Wang S, Guo H, Tian T, Nan K, Wang W: Colon cancer cells secreted CXCL11 via RBP-Jκ to facilitated tumour-associated macrophage-induced cancer metastasis. J Cell Mol Med. 2021, 25 (22): 10575-10590.
Wu Q, Wei J, Zhao C, Xiang S, Shi M, Wang Y: Targeting LncRNA EPIC1 to inhibit human colon cancer cell progression. Aging (Albany NY). 2020, 12 (): .
Al-haidari AA, Syk I, Jirström K, Thorlacius H: CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling. Int J Colorectal Dis. 2013, 28 (11): 1479-87.
Zhu Y, Fu F, Wang Z, Qiu F, Deng T, Du B, Zhu Y, Xi X: Polyphyllin VII is a Potential Drug Targeting CD44 Positive Colon Cancer Cells. Curr Cancer Drug Targets. 2022, 22 (5): 426-435.
Jiang L, Qian J, Yang Y, Fan Y: Knockdown of MON1B Exerts Anti-Tumor Effects in Colon Cancer In Vitro. Med Sci Monit. 2018, 24 (): 7710-7718.
Liu X, Jiang WN, Wang JG, Chen H: Colon cancer bears overexpression of OTUB1. Pathol Res Pract. 2014, 210 (11): 770-3.
Xu W, Zhang Y, Chen L, Qiu F, Zhang B, Wu L, Peng Z, Tang H: Up-regulation of CIT promotes the growth of colon cancer cells. Oncotarget. 2017, 8 (42): 71954-71964.
['Һорауҙарығыҙ йәки тәҡдимдәрегеҙ булһа, беҙгә электрон почта аша хәбәр итегеҙ.']
What is colon cancer?
Colon cancer, also known as colorectal cancer, is a type of cancer that begins in the colon or rectum.
It typically starts as a growth called a polyp, which can develop into cancer over time.
Colon cancer is the third most common cancer in the United States and can be treated if caught early.
Risk factors for colon cancer include age, family history, diet, and lifestyle factors.
Regular screening, such as colonoscopies, can help detect and prevent colon cancer.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
